TY - JOUR
T1 - Improved fluorometric high-performance liquid chromatographic assay for (-)-carbovir in rat blood and urine
AU - Remmel, Rory P.
AU - Huang, Shu Hui
AU - Hoff, David
AU - Zimmerman, Cheryl L.
N1 - Funding Information:
This work was supported in part by Public Health Service Grant ROl AI28236 from the National Institute of Health. The authors wish to thank Dr.
PY - 1990
Y1 - 1990
N2 - Carbovir is a carbocyclic guanosine analogue with potent in vitro activity against the human immuno-deficiency virus. All of the activity resides in the (-)-enantiomer. An ion-paired liquid chromatographic assay for (-)-carbovir was developed on a Spherisorb C8 column with fluorescence detection (275 nm excitation, 345 nm emission). Guanosine nucleosides are fluorescent at a pH < 2.5, and fluorescence detection resulted in a four-fold improvement in the limit of quantitation (0.039 μg/ml) compared to the previously developed assay with ultraviolet detection. Standard curves were processed with an internal standard at (-)-carbovir concentrations of 0.039-40 μg/ml in whole rat blood with a solid-phase extraction technique. Total variability was less than 16% at all concentrations and less than 10% at concentrations > 0.3 μg/ml. Within-day variability was less than 7.5% at concentrations > 0.3 μg/ml. Urine was analyzed directly after dilution and an diethyl ether wash to remove impurities. The total coefficients of variation were less than 10% from 0.5-20 μg/ml in urine. The concentrations of (-)-carbovir in rat blood were detectable for as long as 8 h after intravenous and oral doses of 20 and 60 mg/kg, respectively.
AB - Carbovir is a carbocyclic guanosine analogue with potent in vitro activity against the human immuno-deficiency virus. All of the activity resides in the (-)-enantiomer. An ion-paired liquid chromatographic assay for (-)-carbovir was developed on a Spherisorb C8 column with fluorescence detection (275 nm excitation, 345 nm emission). Guanosine nucleosides are fluorescent at a pH < 2.5, and fluorescence detection resulted in a four-fold improvement in the limit of quantitation (0.039 μg/ml) compared to the previously developed assay with ultraviolet detection. Standard curves were processed with an internal standard at (-)-carbovir concentrations of 0.039-40 μg/ml in whole rat blood with a solid-phase extraction technique. Total variability was less than 16% at all concentrations and less than 10% at concentrations > 0.3 μg/ml. Within-day variability was less than 7.5% at concentrations > 0.3 μg/ml. Urine was analyzed directly after dilution and an diethyl ether wash to remove impurities. The total coefficients of variation were less than 10% from 0.5-20 μg/ml in urine. The concentrations of (-)-carbovir in rat blood were detectable for as long as 8 h after intravenous and oral doses of 20 and 60 mg/kg, respectively.
UR - http://www.scopus.com/inward/record.url?scp=0025614398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025614398&partnerID=8YFLogxK
U2 - 10.1016/S0378-4347(00)82153-2
DO - 10.1016/S0378-4347(00)82153-2
M3 - Article
C2 - 2094697
AN - SCOPUS:0025614398
SN - 0378-4347
VL - 534
SP - 109
EP - 118
JO - Journal of Chromatography B: Biomedical Sciences and Applications
JF - Journal of Chromatography B: Biomedical Sciences and Applications
IS - C
ER -